Advanced search
Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 114, 2008 - Issue 1: Special Issue: Proceedings of the Workshop on Insulin and Cancer, Dusseldorf, October 2007
Submit an article Journal homepage
761
Views
46
CrossRef citations to date
0
Altmetric
Review

Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus

Paolo Rossetti Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
,
Francesca Porcellati Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
,
Carmine G. Fanelli Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
,
Gabriele Perriello Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
,
Elisabetta Torlone Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
&
Professor Geremia B. Bolli Department of Internal Medicine, Endocrinology and Metabolism, University of Perugia, Perugia, Italy
Pages 3-10 | Received 09 Nov 2007, Accepted 21 Nov 2007, Published online: 10 Oct 2008

Citations (46)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lowell R. Schmeltz & Carla Ferrise. (2012) Glycemic Management in the Inpatient Setting. Hospital Practice 40:2, pages 44-55.
Read now
Bridget R Levich. (2011) Diabetes management: optimizing roles for nurses in insulin initiation. Journal of Multidisciplinary Healthcare 4, pages 15-24.
Read now
Steve Fordan & Philip Raskin. (2009) Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review. Vascular Health and Risk Management 5, pages 225-231.
Read now
Lowell R. Schmeltz. (2009) Safe Insulin Use in the Hospital Setting. Hospital Practice 37:1, pages 51-59.
Read now

Articles from other publishers (42)

Louis Monnier, Claude Colette, Abdelilah El Azrak, Noureddine Essekat & Driss Rochd. (2023) Au-delà des insulines actuelles : des réalisations prometteuses et quelques désillusions. Médecine des Maladies Métaboliques 17:1, pages 35-48.
Crossref
Chengshun Li, Dongxu Wang, Ziping Jiang, Yongjian Gao, Liqun Sun, Rong Li, Minqi Chen, Chao Lin & Dianfeng Liu. (2022) Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease. Frontiers in Endocrinology 13.
Crossref
Geremia B. Bolli, Alice Y. Y. Cheng & David R. Owens. (2022) Insulin: evolution of insulin formulations and their application in clinical practice over 100 years. Acta Diabetologica 59:9, pages 1129-1144.
Crossref
Louis Monnier, Claude Colette & David Owens. (2021) Si l'ère des insulines semi-synthétiques et biosynthétiques nous était contée. Médecine des Maladies Métaboliques 15:3, pages 3S32-3S52.
Crossref
Peter Manu, Liliana M. Rogozea & Simona Cernea. (2021) Pharmacological Management of Diabetes Mellitus: A Century of Expert Opinions in Cecil Textbook of Medicine. American Journal of Therapeutics 28:4, pages e397-e410.
Crossref
Xiaoli Sheng, Kannan Yao, Anwen Shao, Sheng Tu, Xinxia Zhang, Ting Chen & Dingguo Yao. (2019) The Role of Insulin Glargine and Human Insulin in the Regulation of Thyroid Proliferation Through Mitogenic Signaling. Frontiers in Endocrinology 10.
Crossref
Davida F. Kruger & Lucia M. Novak. (2019) Role of ultrafast-acting insulin analogues in the management of diabetes. Journal of the American Association of Nurse Practitioners 31:9, pages 537-548.
Crossref
. 2019. Diabetologie. Diabetologie 141 252 .
L. Monnier & C. Colette. (2018) Préparations insuliniques au cours de la dernière décennie.. Médecine des Maladies Métaboliques 12:2, pages 113-127.
Crossref
David Morris. (2018) Why, when and how to use insulin in type 2 diabetes mellitus. Independent Nurse 2018:2, pages 23-26.
Crossref
H. Latrech, S. El Aziz, F. Ajdi, M. Seqat, J. Sadik, G. El Mghari & M. El Hassan Gharbi. (2017) Contrôle glycémique avec insuline glargine : étude observationnelle menée au Maroc auprès de patients diabétiques de type 2 insuffisamment contrôlés par metformine, seule ou en association avec un sulfamide hypoglycémiant et/ou une insuline basale. Médecine des Maladies Métaboliques 11:2, pages 183-187.
Crossref
Lyudmila A. Ruyatkina & Maksim Y. Sorokin. (2016) Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives. Diabetes mellitus 19:2, pages 171-178.
Crossref
Arto Y. Strandberg, Fabian J. Hoti, Timo E. Strandberg, Solomon Christopher, Jari Haukka & Pasi Korhonen. (2016) All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine. PLOS ONE 11:3, pages e0151910.
Crossref
Norou Diawara, Ayodeji Demuren & Eric Gyuricsko. (2016) Impairment of Continuous Insulin Delivery Therapy and Analysis from Graeco-Latin Square Design Model. Journal of Biosciences and Medicines 04:08, pages 40-51.
Crossref
Cassandra E Henderson. (2015) Systematic Literature Review of Basal Bolus Insulin Analogue Therapy during Pregnancy. Obstetrics & Gynecology International Journal 3:2.
Crossref
Vincent C. Woo. (2015) New Insulins and New Aspects in Insulin Delivery. Canadian Journal of Diabetes 39:4, pages 335-343.
Crossref
Avivit Cahn, Roberto Miccoli, Angela Dardano & Stefano Del Prato. (2015) New forms of insulin and insulin therapies for the treatment of type 2 diabetes. The Lancet Diabetes & Endocrinology 3:8, pages 638-652.
Crossref
T. Heise, U. Hövelmann, L. Brøndsted, C. L. Adrian, L. Nosek & H. Haahr. (2015) Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart. Diabetes, Obesity and Metabolism 17:7, pages 682-688.
Crossref
P. Rossetti, F. J. Ampudia-Blasco & J. F. Ascaso. (2014) Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice. Diabetes, Obesity and Metabolism 16:8, pages 695-706.
Crossref
N. Tennagels, S. Welte, M. Hofmann, P. Brenk, R. Schmidt & U. Werner. (2013) Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats. Diabetologia 56:8, pages 1826-1834.
Crossref
S. C. L. Gough, S. Harris, V. Woo & M. Davies. (2013) Insulin degludec: overview of a novel ultra long‐acting basal insulin. Diabetes, Obesity and Metabolism 15:4, pages 301-309.
Crossref
Kathryn N. Suh, Anne E. McCarthy, Maria D. Mileno & Jay S. Keystone. 2013. Principles and Practice of Travel Medicine. Principles and Practice of Travel Medicine 515 530 .
Antonio J. Ribeiro, Raquel Seiça & Francisco Veiga. 2013. Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment. Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment 109 125 .
Giovanni Sartore, Nino Cristiano Chilelli, Silvia Burlina, Paola Di Stefano, Francesco Piarulli, Domenico Fedele, Andrea Mosca & Annunziata Lapolla. (2012) The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). Acta Diabetologica 49:S1, pages 153-160.
Crossref
Azuma Kanatsuka, Koichi Kawai, Koichi Hirao, Hiroki Yokoyama & Masashi Kobayashi. (2012) The initiation of insulin therapy in type 2 diabetic patients treated with oral anti-diabetic drugs: an observational study in multiple institutes across Japan (JDDM27). Diabetology International 3:3, pages 164-173.
Crossref
Abbas E. Kitabchi & Aidar R. Gosmanov. (2012) Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin. The American Journal of the Medical Sciences 344:2, pages 136-141.
Crossref
Thiemo F. Veneman, Fred E. M. G. Storms, Ingo A. Eland & Paul K. P. Bouter. (2012) From insulin detemir to glargine: Effect on glycemic control and psychological wellbeing in patients with diabetes mellitus type 2 in daily practice. Journal of Diabetes Mellitus 02:01, pages 101-108.
Crossref
Irl B. Hirsch & Jay S. Skyler. 2012. Atlas of Diabetes. Atlas of Diabetes 95 113 .
Bin Wang, Ayodeji Demuren, Eric Gyuricsko & Hui Hu. (2010) An experimental study of pulsed micro-flows pertinent to continuous subcutaneous insulin infusion therapy. Experiments in Fluids 51:1, pages 65-74.
Crossref
Geremia B. BolliAnna Marinelli AndreoliPaola Lucidi. (2011) Optimizing the Replacement of Basal Insulin in Type 1 Diabetes Mellitus: No Longer an Elusive Goal in the Post-NPH Era. Diabetes Technology & Therapeutics 13:S1, pages S-43-S-52.
Crossref
Francesca PorcellatiGeremia B. BolliCarmine G. Fanelli. (2011) Pharmacokinetics and Pharmacodynamics of Basal Insulins. Diabetes Technology & Therapeutics 13:S1, pages S-15-S-24.
Crossref
F. Javier Ampudia-BlascoPaolo RossettiJuan F. Ascaso. (2011) Basal Plus Basal–Bolus Approach in Type 2 Diabetes. Diabetes Technology & Therapeutics 13:S1, pages S-75-S-83.
Crossref
Antonio Hernández Mijares, Eva Solá Izquierdo, Katherinne García Malpartida & Danilo Verge. (2010) Seguridad de los análogos de insulina: qué evaluar, cómo hacerlo y cómo interpretar los resultados. Endocrinología y Nutrición 57:8, pages 376-380.
Crossref
Edith M. Heintjes, Trine L. Thomsen, Fernie J. A. Penning-van Beest, Torsten E. Christensen & Ron M. C. Herings. (2010) Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes. Advances in Therapy 27:4, pages 211-222.
Crossref
Mohsen Eledrisi, Helena W. Rodbard, Paul S. Jellinger, María Jesús del Castillo Palma, Francisco José García Hernández, Julio Sánchez Román, Cary N. Mariash, Sylvia J. Shaw & Stefan Bughi. (2010) Comments On the Aace/Ace Statement on Glycemic Control for Patients With Type 2 Diabetes Mellitus. Endocrine Practice 16:1, pages 130-135.
Crossref
Vivekanandan Kannan, Pradeep Narayanaswamy, Deepak Gadamsetty, Partha Hazra, Anand Khedkar & Harish Iyer. (2009) A tandem mass spectrometric approach to the identification of O-glycosylated glargine glycoforms in active pharmaceutical ingredient expressed in Pichia pastoris . Rapid Communications in Mass Spectrometry 23:7, pages 1035-1042.
Crossref
B. Sheldon, D. Russell-Jones & J. Wright. (2009) Insulin analogues: an example of applied medical science. Diabetes, Obesity and Metabolism 11:1, pages 5-19.
Crossref
C. Cobelli, C. Dalla Man, G. Sparacino, L. Magni, G. De Nicolao & B.P. Kovatchev. (2009) Diabetes: Models, Signals, and Control. IEEE Reviews in Biomedical Engineering 2, pages 54-96.
Crossref
N. A. Ali, J. S. Krinsley & J. -C. Preiser. 2009. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine 728 737 .
N. A. Ali, J. S. Krinsley & J.-C. Preiser. 2009. Intensive Care Medicine. Intensive Care Medicine 728 737 .
Renzo Cordera, Barbara Salani & Lucia Briatore. (2009) Insulin analogues: fears, facts and fantasies. Diabetes/Metabolism Research and Reviews 25:1, pages 50-51.
Crossref
D.R. OwensG.B. Bolli. (2008) Beyond the Era of NPH Insulin—Long-Acting Insulin Analogs: Chemistry, Comparative Pharmacology, and Clinical Application. Diabetes Technology & Therapeutics 10:5, pages 333-349.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.